Vivos Therapeutics Inc (VVOS) Stock Price, Quote & News

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children....

Industry: Medical Devices

Sector: Healthcare

Phone: 844 672 4357

Website: www.vivos.com

Address:

7921 Southpark Plaza, Suite 210, Littleton, United States

Loopi Apr. 25 at 5:10 PM

$VVOS In order to be cash flow in 2026 they will have from your accounts 🤣🔜🔜🔻🔻 All scamming your emotions and mentality

0 · Reply

Loopi Apr. 25 at 3:51 PM

$VVOS you all need a miracle to go back above $2 lol 🤣🤣🔻👋 Never going back its all over

0 · Reply

Loopi Apr. 25 at 3:26 PM

$VVOS Next week target 🎯 >> $0.6

0 · Reply

Loopi Apr. 25 at 3:06 PM

$VVOS This going for another Reverse Split “ If not i will quit trading 🤣🔻🔜🔜

0 · Reply

Loopi Apr. 25 at 1:27 PM

$VVOS The market punish the burning and its investors for a reason 👍🛑🛑

0 · Reply

Loopi Apr. 25 at 1:26 PM

$VVOS failed technology failed management failed execution everything lead the stock below $1 for a reason 🤣🔻🔻👋👋

0 · Reply

Loopi Apr. 25 at 1:25 PM

$VVOS You will die to see it above $1 or $2 its over after Reverse Split maybe 😂🔻🔻🔜 its the end period of this scam stock

0 · Reply

Peaceouty Apr. 24 at 8:59 PM

$VVOS That’s rough guys.. not buying yet.

1 · Reply

Giovannirs3 Apr. 24 at 8:50 PM

$VVOS 👇

0 · Reply

gforce77 Apr. 24 at 8:47 PM

$VVOS is clouded by Loopi, who feels the need to always be at the top of the thread trashing this company. Know what you own, can't emphsize it any better than that. Officially muted, not worth the aggravation

1 · Reply

Vivos Therapeutics Earnings Call Transcript: Q4 2025

Apr 15, 2026, 4:20 PM EDT - 10 days ago

Vivos Therapeutics Reports Full Year 2025 Financial Results

Apr 15, 2026, 8:45 AM EDT - 10 days ago

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

Apr 7, 2026, 8:45 AM EDT - 18 days ago

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

Mar 26, 2026, 8:45 AM EDT - 4 weeks ago

Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market

Mar 17, 2026, 8:45 AM EDT - 5 weeks ago

Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy

Feb 5, 2026, 8:45 AM EST - 2 months ago

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Feb 3, 2026, 6:23 AM EST - 2 months ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter

CERT ZLAB

Jan 20, 2026, 5:31 PM EST - 3 months ago

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

Jan 16, 2026, 8:00 AM EST - 3 months ago

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Dec 16, 2025, 11:00 AM EST - 4 months ago

Vivos Therapeutics Transcript: Fireside Chat

Dec 16, 2025, 8:45 AM EST - 4 months ago

Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan

Nov 19, 2025, 5:00 PM EST - 5 months ago

Vivos Therapeutics Earnings Call Transcript: Q3 2025

Nov 19, 2025, 4:20 PM EST - 5 months ago

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Nov 19, 2025, 8:30 AM EST - 5 months ago

Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call

Sep 30, 2025, 8:30 AM EDT - 7 months ago

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

Sep 17, 2025, 8:30 AM EDT - 7 months ago

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment

Aug 19, 2025, 5:00 PM EDT - 8 months ago

Vivos Therapeutics Earnings Call Transcript: Q2 2025

Aug 19, 2025, 4:20 PM EDT - 8 months ago

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

Aug 19, 2025, 8:30 AM EDT - 8 months ago

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

Jun 26, 2025, 8:30 AM EDT - 10 months ago

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q1 2025

May 14, 2025, 9:15 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:20 PM EDT - 1 year ago

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Feb 18, 2025, 12:00 PM EST - 1 year ago

Vivos Therapeutics Transcript: Fireside Chat

Dec 23, 2024, 8:00 AM EST - 1 year ago

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q3 2024

Nov 13, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Oct 8, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Sep 18, 2024, 7:00 AM EDT - 1 year ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Aug 14, 2024, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 14, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Jun 27, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Jun 12, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q1 2024

May 14, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

May 14, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q4 2023

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Mar 28, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Feb 6, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Jan 8, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA

Dec 11, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

Nov 29, 2023, 11:09 AM EST - 2 years ago

Vivos Therapeutics' stock soars as sleep apnea device gets regulatory clearance

Nov 29, 2023, 7:44 AM EST - 2 years ago

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Nov 29, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Nov 14, 2023, 5:00 PM EST - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q3 2023

Nov 14, 2023, 4:05 PM EST - 2 years ago

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Nov 9, 2023, 4:30 PM EST - 2 years ago

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Closes $4 Million Private Placement

Oct 26, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Reverse Stock Split

Oct 24, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare

Oct 11, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine

Oct 5, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion

Oct 4, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers

Oct 2, 2023, 7:30 AM EDT - 2 years ago

New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference

Aug 16, 2023, 6:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q2 2023

Aug 16, 2023, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update

Jun 8, 2023, 5:00 PM EDT - 3 years ago

Vivos Therapeutics Earnings Call Transcript: Q1 2023

Mar 30, 2023, 5:00 PM EDT - 3 years ago

Vivos Therapeutics Earnings Call Transcript: Q4 2022

Dec 20, 2022, 5:00 PM EST - 3 years ago

Vivos Therapeutics Earnings Call Transcript: Q3 2022

May 16, 2022, 4:17 AM EDT - 4 years ago

Vivos Therapeutics Earnings Call Transcript: Q1 2022

Mar 31, 2022, 8:00 AM EDT - 4 years ago

Vivos Therapeutics Earnings Call Transcript: Q4 2021

Nov 14, 2021, 7:00 PM EST - 4 years ago

Vivos Therapeutics Earnings Call Transcript: Q3 2021

Aug 11, 2021, 8:00 PM EDT - 5 years ago

Vivos Therapeutics Earnings Call Transcript: Q2 2021

May 17, 2021, 5:52 AM EDT - 5 years ago

Vivos Therapeutics Earnings Call Transcript: Q1 2021

Loopi Apr. 25 at 5:10 PM

$VVOS In order to be cash flow in 2026 they will have from your accounts 🤣🔜🔜🔻🔻 All scamming your emotions and mentality

0 · Reply

Loopi Apr. 25 at 3:51 PM

$VVOS you all need a miracle to go back above $2 lol 🤣🤣🔻👋 Never going back its all over

0 · Reply

Loopi Apr. 25 at 3:26 PM

$VVOS Next week target 🎯 >> $0.6

0 · Reply

Loopi Apr. 25 at 3:06 PM

$VVOS This going for another Reverse Split “ If not i will quit trading 🤣🔻🔜🔜

0 · Reply

Loopi Apr. 25 at 1:27 PM

$VVOS The market punish the burning and its investors for a reason 👍🛑🛑

0 · Reply

Loopi Apr. 25 at 1:26 PM

$VVOS failed technology failed management failed execution everything lead the stock below $1 for a reason 🤣🔻🔻👋👋

0 · Reply

Loopi Apr. 25 at 1:25 PM

$VVOS You will die to see it above $1 or $2 its over after Reverse Split maybe 😂🔻🔻🔜 its the end period of this scam stock

0 · Reply

Peaceouty Apr. 24 at 8:59 PM

$VVOS That’s rough guys.. not buying yet.

1 · Reply

Giovannirs3 Apr. 24 at 8:50 PM

$VVOS 👇

0 · Reply

gforce77 Apr. 24 at 8:47 PM

1 · Reply

Loopi Apr. 24 at 8:44 PM

$VVOS in order to move up like other stocks must do Reverse Split first 🖌️ Poor company

0 · Reply

Loopi Apr. 24 at 8:24 PM

$VVOS Believe loopi 🔜 Nothing hold it to visit down to $0.40 anytime this coming weeks🤣🔻🔻👋

0 · Reply

Loopi Apr. 24 at 8:15 PM

$VVOS if you buy this everyday you lose at least 5% a day 🤣🤣🔻🔻🔻🔻 what scam of hunting people

0 · Reply

Giovannirs3 Apr. 24 at 8:15 PM

$VVOS ➖️💯

0 · Reply

jeffthechef Apr. 24 at 7:34 PM

$VVOS seriously oversold!!! What a great price to buy or add. The CEO is completely aware of the price and is working behind the scenes to get the price up. Shorts are gonna get smacked around shortly. Mark it!!

1 · Reply

Loopi Apr. 24 at 7:27 PM

$VVOS Goodbye forever 😂😂🔜🔜🔻🩸🩸🩸🩸🩸🩸

0 · Reply

Loopi Apr. 24 at 7:24 PM

$VVOS new low coming and more 🤣🔻🔻👋💩

0 · Reply

Giovannirs3 Apr. 24 at 7:18 PM

$VVOS 🤣🤣

0 · Reply

gforce77 Apr. 24 at 7:16 PM

$VVOS did you watch the youtube video someone posted yesterday? Highly recommend that vs spamming the boards constantly with nonsense.

0 · Reply

Loopi Apr. 24 at 7:09 PM

$VVOS Zero of Movement 🤣🔻🔻what a stock is that 👋🔜

0 · Reply

Giovannirs3 Apr. 24 at 6:57 PM

$VVOS 👍👁🚆

0 · Reply

Giovannirs3 Apr. 24 at 6:43 PM

$VVOS someone explain to this one below.... 77.. which was previously $50 🤣🤣➖️💯

0 · Reply

Market Cap	12.08M
Revenue (ttm)	17.44M
Net Income (ttm)	-21.17M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-121.39%
Debt to Equity Ratio	-5.69

Volume	151,200
Avg Vol	223,578
Day's Range	N/A - N/A
Shares Out	13.49M
Stochastic %K	3%
Beta	6.93
Analysts	Sell
Price Target	$2.42